RAD inhibition of sarcoma growth: implications for laryngeal transplantation

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 28, Issue 6, 2007, Pages 375-378

  Knott, Philip Daniel ^a   Tamai, Hidemasa ^a   Strome, Marshall ^a   Van Lente, Fredrick ^a   Shu, Suyu ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RAPAMYCIN; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; CANCER INHIBITION; CONTROLLED STUDY; FIBROSARCOMA; GRAFT REJECTION; GROWTH INHIBITION; IMMUNOSUPPRESSIVE TREATMENT; LARYNX SURGERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SARCOMA CELL; TRANSPLANTATION; TUMOR RECURRENCE; TUMOR VOLUME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FIBROSARCOMA; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; SIROLIMUS; SOFT TISSUE NEOPLASMS; TUMOR BURDEN;

EID: 35548929520     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2006.11.003     Document Type: Article

References (18)

1. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl (1998) 147-158
2. Sedrani R., Cottens S., Kallen J., et al. Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant Proc 30 (1998) 2192-2194
3. Kahan B.D., Kaplan B., Lorber M.I., et al. RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection. Transplantation 71 10 (2001) 1400-1406
4. Schuurman H.J., Schuler W., Ringers J., et al. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation. Transplant Proc 30 (1998) 2198-2199
5. Kovarik J.M., Kaplan B., Tedesco Silva H., et al. Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range. Transplantation 73 (2002) 920-925
6. Kovarik J.M., Eisen H., Dorent R., et al. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. J Heart Lung Transplant 22 (2003) 1117-1125
7. Hoyer P.F., Ettenger R., Kovarik J.M., et al. Everolimus in pediatric de novo renal transplant patients. Transplantation 75 (2003) 2082-2085
8. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
9. Schuler W., Sedrani R., Cottens S., et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64 (1997) 36-42
10. Farb A., John M., Acampado E., et al. Oral everolimus inhibits in-stent neointimal growth. Circulation 106 (2002) 2379-2384
11. s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res 56 (1996) 3895-3897
12. Muthukkumar S., Ramesh T.M., and Bondada S. Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. Transplantation 60 (1995) 264-270
13. Rohde J., Heitman J., and Cardenas M.E. The TOR kinases link nutrient sensing to cell growth. J Biol Chem 276 13 (2001) 9583-9586
14. Huang S., and Houghton P.J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr Opin Investig Drugs 3 2 (2002) 295-304
15. Matsumoto Y., Hof A., Baumlin Y., et al. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice. Transplantation 76 (2003) 1166-1170
16. Majewski M., Korecka M., Joergensen J., et al. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation 75 10 (2003) 1710-1717
17. Adams G. Malignant tumors of the larynx and hypopharynx. In: Cummings C.W., Fredrickson J.M., Harker L.A., et al. (Eds). Otolaryngology head and neck surgery. 3rd ed (1998), Mosby, Philadelphia (PA) 2130-2175
18. Strome M. Human laryngeal transplantation: considerations and implications. Microsurgery 20 (2000) 372-374